Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Pramoxine (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pramocaine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pramocaine hydrochloride (substance) |
Is a |
False |
Pramocaine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing hydrocortisone and pramocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pramocaine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing neomycin and polymyxin B and pramocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pramocaine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Bacitracin- and neomycin- and polymyxin B- and pramocaine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pramocaine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Pramocaine- and zinc oxide-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pramocaine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydrocortisone 1% / Pramocaine 1% foam enema (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pramocaine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing pramocaine in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pramocaine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing pramocaine in rectal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pramocaine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pramocaine-containing product in otic dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pramocaine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydrocortisone 1% + Pramocaine 1% conventional release rectal foam |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pramocaine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pramocaine hydrochloride (substance) |
Is modification of (attribute) |
True |
Pramocaine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pramocaine-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pramocaine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only bacitracin and neomycin and polymyxin B and pramocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pramocaine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing only neomycin and polymyxin B and pramocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pramocaine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing only hydrocortisone and pramocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pramocaine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pramocaine and zinc oxide only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pramocaine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only pramocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pramocaine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pramocaine only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pramocaine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only pramocaine in rectal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pramocaine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only pramocaine in otic dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pramocaine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydrocortisone and pramocaine only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pramocaine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydrocortisone- and pramocaine-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pramocaine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |